DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

JUNE 21, 2024

milla1cf Fri, 06/21/2024 - 20:10 June 21, 2024 — UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards EVOQUE system. by the Food and Drug Administration.

Tricuspid 105

Tricuspid Quality of Life Open-Heart Surgery Interventional Cardiology 105

DAIC

FEBRUARY 9, 2024

Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. The first 100 minimally invasive tricuspid procedures were done as part of the TRISCEND II clinical trial. Image by Getty. Image by Getty. Food and Drug Administration (FDA).

Tricuspid 105

Tricuspid Interventional Cardiology Open-Heart Surgery Bicuspid/Mitral 105

Med Page Today

JUNE 8, 2024

(MedPage Today) -- NEW YORK CITY -- Recent device approvals officially put transcatheter tricuspid valve intervention (TTVI) on the map for symptomatic severe tricuspid regurgitation (TR), though workforce challenges and a less-than-compelling.

Tricuspid 96

Tricuspid 96

Med Page Today

JANUARY 26, 2025

(MedPage Today) -- LOS ANGELES -- Cardiac surgeons were urged to readjust their attitudes toward the tricuspid valve if they want to keep some footing in a rapidly evolving field dominated by transcatheter innovations. At the Society of Thoracic.

Tricuspid 98

Tricuspid Innovation 98

DAIC

APRIL 16, 2025

tim.hodson Wed, 04/16/2025 - 14:19 April 16, 2025 An artificial intelligence (AI) program trained to review images from a common medical test can detect early signs of tricuspid heart valve disease and may help doctors diagnose and treat patients sooner, according to research from the Smidt Heart Institute at Cedars-Sinai. Photo: Getty.

Heart Valves 71

Heart Valves Tricuspid Echocardiogram Research 71

JAMA Cardiology

APRIL 15, 2025

This study describes the development and testing of a deep learning computer vision workflow for identifying color Doppler echocardiogram videos and characterizing tricuspid regurgitation presence and severity using cohorts from 2 sites.

Tricuspid 92

Tricuspid Echocardiogram 92

DAIC

APRIL 25, 2024

milla1cf Thu, 04/25/2024 - 17:21 April 25, 2024 — Atlantic Health System ’s Morristown Medical Center treated the first patient in New Jersey using Edwards Lifesciences EVOQUE tricuspid valve replacement, the first transcatheter therapy to receive U.S. According to National Institutes of Health an estimated 1.6 million people in the U.S.

Tricuspid 111

Tricuspid Quality of Life Hospital Nursing 111

Society of Thoracic Surgeons - Congenital

APRIL 1, 2024

Resource Isolated Tricuspid Valve Surgery Risk Calculator kchalko Mon, 04/01/2024 - 13:31 Isolated Tricuspid Valve Surgery Risk Calculator Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results.

Tricuspid 86

Tricuspid Outcomes 86

DAIC

FEBRUARY 2, 2024

Photo: Edwards Lifesciences milla1cf Fri, 02/02/2024 - 09:33 February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is the first transcatheter therapy to receive U.S. Food and Drug Administration (FDA) approval for the treatment of tricuspid regurgitation (TR).

Tricuspid 100

Tricuspid Quality of Life Bicuspid/Mitral Innovation 100

HCPLive

FEBRUARY 2, 2024

The FDA approval of Edwards Lifesciences EVOQUE tricuspid valve replacement system for treatment of symptomatic severe tricuspid regurgitation is the first of its kind for a transcatheter therapy.

Tricuspid 80

Tricuspid 80

Med Page Today

FEBRUARY 12, 2024

(MedPage Today) -- FDA staff questioned the evidence for clinical benefit with the TriClip G4 transcatheter edge-to-edge repair (TEER) system for severe tricuspid regurgitation (TR) in documents released ahead of the agency's Circulatory System.

Tricuspid 93

Tricuspid Document 93

The New England Journal of Medicine

JANUARY 8, 2025

In a randomized trial involving patients with severe tricuspid regurgitation, transcatheter tricuspid-valve replacement was superior to medical therapy at 1 year.

Tricuspid 75

Tricuspid 75

DAIC

FEBRUARY 15, 2024

Food and Drug Administration ( FDA ) confirmed 13 to 1, with 0 abstention that the benefits of Abbott's TriClip™ transcatheter edge-to-edge repair (TEER) system outweighed the risks for the treatment of people with tricuspid regurgitation (TR). On the final question of the benefit of TriClip versus the risk, the vote was 13 to 1 in favor.

Tricuspid 102

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral 102

Circulation

APRIL 25, 2024

Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. This review highlights the important background, anatomic considerations, therapeutic options, and future directions with regard to treatment of tricuspid valve disease. Circulation, Ahead of Print.

Tricuspid 80

Tricuspid Pacemaker Heart Failure Pulmonary 80

Frontiers in Cardiovascular Medicine

MARCH 3, 2024

By contrast, the right-sided diseases, particularly the tricuspid valve (TV) and associated regurgitation, still have much to be delineated. Worsening tricuspid regurgitation (TR) is associated with increased mortality; the non-invasive management is suboptimal; and surgical approaches carry significant risk.

Tricuspid 69

Tricuspid Anatomy Heart Disease 69

American College of Cardiology

DECEMBER 12, 2023

What are the predictors of tricuspid regurgitation (TR) progression and the prognostic impact of TR progression?

Tricuspid 65

Tricuspid Article 65

American College of Cardiology

JULY 17, 2024

What is the effect of a transvenous implantable cardioverter-defibrillator (TV-ICD) on tricuspid regurgitation (TR) severity, and secondarily, on right ventricular (RV) size and function?

Tricuspid 64

Tricuspid Defibrillator Article 64

European Journal of Heart Failure

MARCH 7, 2024

Changes in right ventricular (RV) function and clinical outcomes after tricuspid transcatheter edge-to-edge repair (T-TEER). Among patients with baseline RVFAC <35%, a smaller RV diameter and a greater reduction of tricuspid regurgitation were predictors for the RV responder.

Tricuspid 76

Tricuspid Outcomes Heart Failure Hospital 76

CardiacWire

FEBRUARY 4, 2024

Edwards Lifesciences ended last week with the biggest structural interventions launch that we’ve seen in some time, announcing the FDA approval of its EVOQUE transcatheter tricuspid valve replacement system (TTVR). The post Edwards EVOQUE First FDA-Approved Transcatheter Tricuspid Regurgitation Treatment appeared first on Cardiac Wire.

Tricuspid 59

Tricuspid Quality of Life Medicare 59

Heart BMJ

FEBRUARY 23, 2024

Significant secondary tricuspid regurgitation (STR) has increasing prevalence with age, it is associated with impaired quality of life, and it is an independent predictor of patients’ morbidity and mortality. 3 4 However, the association of RA function with outcomes in patients with STR received less attention.

Tricuspid 74

Tricuspid Quality of Life Outcomes 74

All About Cardiovascular System and Disorders

MARCH 30, 2024

Transcipt of video: Mild tricuspid regurgitation is often noted on echocadiogram reports and sometimes causes a little bit of worry and a lot of questions are asked on mild tricuspid regurgitation. What is this mild tricuspid regurgitation? And mild tricuspid regurgitation is just a small leak from the tricuspid valve.

Tricuspid 52

Tricuspid Echocardiogram Bicuspid/Mitral Pulmonary 52

Frontiers in Cardiovascular Medicine

MAY 29, 2025

An echocardiogram showed multiple masses on both the mitral and tricuspid valve leaflets. The follow-up echocardiogram at 6months showed no recurrence and competence of both the mitral and tricuspid valves with minimal regurgitation.

Tricuspid 52

Tricuspid Embolism Echocardiogram Bicuspid/Mitral 52

Med Page Today

FEBRUARY 14, 2024

(MedPage Today) -- FDA advisors were nearly unanimous in backing the TriClip G4 transcatheter edge-to-edge repair (TEER) device as a treatment for severe tricuspid regurgitation (TR). During an advisory committee meeting on Tuesday, the FDA's.

Tricuspid 64

Tricuspid 64

American College of Cardiology

OCTOBER 27, 2024

Food and Drug Administration (FDA) this year for tricuspid regurgitation (TR) are safe, effective and improve quality of life (QOL) at one year, according to studies published in JACC and simultaneously being presented at TCT 2024. Two devices approved by the U.S.

Quality of Life 56

Quality of Life Tricuspid Article 56

Med Page Today

APRIL 1, 2025

(MedPage Today) -- CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF) hospitalization for this technology.

Tricuspid 52

Tricuspid Heart Failure Hospital Technology 52

Science Daily - Heart Disease

APRIL 9, 2024

Medical researchers have performed a successful transcatheter tricuspid valve repair procedure with a groundbreaking catheter.

Tricuspid 127

Tricuspid Research 127

All About Cardiovascular System and Disorders

MARCH 30, 2024

In Ebstein’s anomaly, there is downward or apical displacement of posterior and septal tricuspid leaflets. The anterior leaflet is not displaced, but is elongated to meet the other leaflets, so that when it closes, a loud sound, tricuspid sound, is produced, which is called as the sail sound.

Tricuspid 52

Tricuspid Arrhythmia Congenital Heart Disease Electrophysiology 52

DAIC

JUNE 10, 2024

milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. The recent approval of the tricuspid clip device by the U.S.

Heart Valves 109

Heart Valves Tricuspid Open-Heart Surgery Quality of Life 109

Med Page Today

AUGUST 31, 2024

(MedPage Today) -- LONDON -- Tricuspid transcatheter edge-to-edge repair (T-TEER) improved how well patients functioned and felt without major cardiovascular events in the first academic randomized trial to affirm the pivotal trial findings.

Tricuspid 52

Tricuspid Academic 52

HCPLive

FEBRUARY 14, 2024

FDA advisory committee votes 13-1 that the benefits outweigh the risk of use for Abbott's TriClip for tricuspid regurgitation, pending FDA decision expected in 2024.

Tricuspid 59

Tricuspid 59

DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

American College of Cardiology

AUGUST 31, 2024

trial was to assess the efficacy and safety of tricuspid transcatheter edge-to-edge repair (T-TEER) + guideline-directed medical therapy (GDMT) compared with GDMT alone among patients with symptomatic ≥ severe tricuspid regurgitation (TR). The goal of the TRI.Fr

Tricuspid 43

Tricuspid Article 43

Med Page Today

MARCH 25, 2025

(MedPage Today) -- Based on the finalized national coverage determination (NCD) for transcatheter tricuspid valve replacement, Medicare will cover the procedure when used for an FDA-approved indication, and reimbursement will hinge on it being.

Tricuspid 52

Tricuspid Reimbursement Medicare 52

Becker's Hospital Review - Cardiology

FEBRUARY 25, 2025

based WVU Medicine's Heart and Vascular Institute have performed the first transcatheter tricuspid valve replacements in the state and region. A team at Morgantown, W.Va.-based

Tricuspid 52

Tricuspid 52

Medical Xpress - Cardiology

NOVEMBER 5, 2024

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement in symptoms, function, and quality of life, according to a study published online Oct. 27 to 30 in Washington, D.C.

Tricuspid 40

Tricuspid Quality of Life Research 40

Med Page Today

OCTOBER 31, 2024

(MedPage Today) -- The Evoque transcatheter tricuspid valve replacement (TTVR) system continued to show significant benefits 1 year after implant, according to an update from the TRISCEND II trial. Among study participants with symptomatic, severe.

Tricuspid 52

Tricuspid 52